Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation-Reference-Cited by-同舟云学术

Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation

Published:2016-11-16 Issue:52 Volume:7 Page:86326-86338
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Hui-Yun¹,Xu Wen-Qian¹,Zheng Yuan-yuan²,Omari-Siaw Emmanuel¹,Zhu Yuan¹,Cao Xia¹,Tong Shan-Shan¹,Yu Jiang-nan¹²,Xu Xi-ming¹

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy, Center for Nano Drug/Gene Delivery and Tissue Engineering, Jiangsu University, Zhenjiang, People’s Republic of China

2. School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Octreotide and Octreotide-derived delivery systems;Journal of Drug Targeting;2023-05-23

2. Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation;BMC Complementary Medicine and Therapies;2023-04-20

3. Dual targets of lethal apoptosis and protective autophagy in liver cancer with periplocymarin elicit a limited therapeutic effect;International Journal of Oncology;2023-02-21

4. Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome;Drug Delivery;2022-07-31

5. PEG-4000 formed polymeric nanoparticles loaded with cetuximab downregulate p21 & stathmin-1 gene expression in cancer cell lines;Life Sciences;2022-04